The emerging trend of consuming 5MeO dimethyltryptamine in Canada presents serious risks and challenging statutory issues. Currently, 5meo dimethyltryptamine remains a Schedule I substance under this CDSA, causing its https://lewysssod594893.robobloggo.com/61579784/5-meo-copyright-vaping-in-canada-risks-legality-and-what-you-need-to-know